Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medicago Inc MDCGF

Healthcare Biotechnology


GREY:MDCGF - Post by User

Medicago Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Post by Blueocean102on Oct 12, 2012 10:48pm
313 Views
Post# 20480111

H5 pandemic Vaccine phase 2 infos

H5 pandemic Vaccine phase 2 infos

I got  an answer from Medicago :  The H5 vaccine Phase I trial (GLA adjuvant) does not replace the H5 pandemic Vaccine phase 2. Following the completion of phase 2, there is the potential to enter into capacity reservation or other contracts with governments.

 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities